Sorry, I don't understand your search. ×
Back to Search Start Over

New Insights Into the Role of Cav2 Protein Family in Calcium Flux Deregulation in Fmr1-KO Neurons.

Authors :
Castagnola, Sara
Delhaye, Sébastien
Folci, Alessandra
Paquet, Agnès
Brau, Frédéric
Duprat, Fabrice
Jarjat, Marielle
Grossi, Mauro
Béal, Méline
Martin, Stéphane
Mantegazza, Massimo
Bardoni, Barbara
Maurin, Thomas
Source :
Frontiers in Molecular Neuroscience; 9/27/2018, p1-13, 13p
Publication Year :
2018

Abstract

Fragile X syndrome (FXS), the most common form of inherited intellectual disability (ID) and a leading cause of autism, results from the loss of expression of the Fmr1 gene which encodes the RNA-binding protein Fragile X Mental Retardation Protein (FMRP). Among the thousands mRNA targets of FMRP, numerous encode regulators of ion homeostasis. It has also been described that FMRP directly interacts with Ca<superscript>2+</superscript> channels modulating their activity. Collectively these findings suggest that FMRP plays critical roles in Ca<superscript>2+</superscript> homeostasis during nervous system development. We carried out a functional analysis of Ca<superscript>2+</superscript> regulation using a calcium imaging approach in Fmr1-KO cultured neurons and we show that these cells display impaired steady state Ca<superscript>2+</superscript> concentration and an altered entry of Ca<superscript>2+</superscript> after KCl-triggered depolarization. Consistent with these data, we show that the protein product of the Cacna1a gene, the pore-forming subunit of the Ca<subscript>v</subscript>2.1 channel, is less expressed at the plasma membrane of Fmr1-KO neurons compared to wild-type (WT). Thus, our findings point out the critical role that Ca<subscript>v</subscript>2.1 plays in the altered Ca<superscript>2+</superscript> flux in Fmr1-KO neurons, impacting Ca<superscript>2+</superscript> homeostasis of these cells. Remarkably, we highlight a new phenotype of cultured Fmr1-KO neurons that can be considered a novel cellular biomarker and is amenable to small molecule screening and identification of new drugs to treat FXS. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
16625099
Database :
Complementary Index
Journal :
Frontiers in Molecular Neuroscience
Publication Type :
Academic Journal
Accession number :
132026975
Full Text :
https://doi.org/10.3389/fnmol.2018.00342